{"id":2757,"date":"2021-02-15T15:00:30","date_gmt":"2021-02-15T04:00:30","guid":{"rendered":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/low-dose-cbd-is-now-over-the-counter\/"},"modified":"2025-11-10T12:45:26","modified_gmt":"2025-11-10T01:45:26","slug":"low-dose-cbd-is-now-over-the-counter","status":"publish","type":"post","link":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/low-dose-cbd-is-now-over-the-counter\/","title":{"rendered":"Low-dose CBD is Now Over the Counter"},"content":{"rendered":"

As of February, 1st<\/sup> this year \u201clow-dose cannabidiol (CBD)\u201d has been available in the now lesser regulated \u2018OTC\u2019 (over the counter) space.<\/p>\n

The TGA had been \u2018dancing\u2019 with the \u2018vote for medicine\u2019 campaign<\/a>, and whilst not fully endorsing it, has ushered in a sub-set of classification and rescheduled this particular cannabinoid. Now, this new line certainly opens the door to significantly greater promotion and use of a substance still not fully understood \u2013 and a product certainly with clouds over both efficacy and safety<\/a> \u2013 regardless of \u2018anecdotal testimony\u2019<\/a><\/p>\n

According to the CBD Insider<\/a><\/em><\/p>\n

Australia\u2019s Therapeutic Goods Administration (TGA) announced their down-scheduling of \u201clow-dose cannabidiol (CBD)\u201d from a Schedule 4 substance to a Schedule 3 substance in mid-December of last year, a decision that just went into effect this Monday, February 1. <\/em><\/p>\n

This particular jump is a monumental one for Australian CBD producers and customers alike, since it marks the divide between prescription-only (Schedule 4) and over-the-counter (Schedule 3) status. <\/em><\/p>\n

In order to qualify for this down-scheduling, CBD products have to meet Schedule 3 criteria, chief among which is the requirement on pharmacists to adhere to the newly increased 150mg\/day maximum daily dose.<\/em><\/p>\n

Once a product is approved by the TGA, it is placed in the Australian Register of Therapeutic Goods (ARTG), and can thereafter be sold over the counter.<\/em><\/p>\n

Of course, cannabis derived formulations have no curative properties<\/a><\/em> of any kind, and formulations for useful \u2018medical application\u2019 are very sparce despite, the now decade long thorough investigation, and at very best current preparations may only alleviate some conditions, but not without potential harmful and\/or long-term side-effects.  The placebo effect of cannabis-based therapeutics is widely known, and whilst a placebo that does no other harms, can be very beneficial on a subjective level, ones that do have detrimental potential are only emerging, and the trade off of one alleviated symptom for another is not good medicine \u2013 particularly when net health outcome may be worse<\/a>.<\/p>\n

Whilst we are all excited about, and look forward to, advances in science and medicine that truly benefit our health, not just alleviate a symptom (or worse simply a \u2018felt need\u2019) we want to ensure that best-practice science, not market-driven greed and hype (historically a source of many pharmaceutical catastrophe\u2019s) are what drive health-care compassion.<\/p>\n

It\u2019s important all consumers keep across all the research \u2013 the good, bad and ugly, and make wise beneficial decisions for both short and long-term.<\/p>\n

For more…<\/p>\n

NEW REPORT: CBD Companies Using \u201cResearch\u201d As Marketing Tool Could Mislead Consumers And Risk Public (4safecbd.org)<\/a><\/strong><\/span><\/p>\n

<\/a>https:\/\/www.dalgarnoinstitute.org.au\/resources\/next-phase-blog\/1282-over-the-counter-cbd-proper-research-caution-regulation-needed.html<\/a><\/strong><\/span><\/p>\n

Concerns_about_CBD_19-03-20.pdf<\/a><\/strong><\/span><\/p>\n

ConsumersForSafeCBD_UnsubstaniatedTherapeuticClaims2020.pdf<\/a><\/strong><\/span><\/p>\n

\"ConcernsCBD\"<\/p>\n

Compiled by Dalgarno Institute Research Team<\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

As of February, 1st this year \u201clow-dose cannabidiol (CBD)\u201d has been available in the now lesser regulated \u2018OTC\u2019 (over the counter) space. The TGA had been \u2018dancing\u2019 with the \u2018vote for medicine\u2019 campaign, and whilst not fully endorsing it, has ushered in a sub-set of classification and rescheduled this particular cannabinoid. Now, this new line […]<\/p>\n","protected":false},"author":2,"featured_media":2755,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":"","_wp_rev_ctl_limit":""},"categories":[46],"tags":[],"class_list":["post-2757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-next-phase-platform"],"_links":{"self":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/2757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/comments?post=2757"}],"version-history":[{"count":0,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/posts\/2757\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/media\/2755"}],"wp:attachment":[{"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/media?parent=2757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/categories?post=2757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/wp-json\/wp\/v2\/tags?post=2757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}